AstraZeneca PLC (NASDAQ:AZN)
| 67.72 Delayed Data As of Sep 29 |  +0.30 / +0.44%Today’s Change | 53.52 Today|||52-Week Range 76.56 | -0.12% Year-to-Date |
Latest AZN News | Press Releases
Today’s Trading
| Previous close | 67.42 |
| Today’s open | 68.78 |
| Day’s range | 67.59 - 68.78 |
| Volume | 245,759 |
| Average volume (3 months) | 5,047,089 |
| Market cap | $209.9B |
Data as of 4:00pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | +2,588.61% |
| Earnings growth (this year) | +10.40% |
| Earnings growth (next 5 years) | +12.35% |
| Revenue growth (last year) | +17.23% |
| P/E ratio | 34.3 |
| Price/Sales | 4.77 |
| Price/Book | 5.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | -0.45 | -0.44% |
| PFEPfizer | +1.08 | +3.38% |
| MRKMerck | -1.30 | -1.25% |
| ABBVAbbVie | -3.15 | -2.07% |
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | November 9, 2023 |
| EPS forecast (this quarter) | $0.88 |
| Annual revenue (last year) | $44.4B |
| Annual profit (last year) | $3.3B |
| Net profit margin | 7.41% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
